ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/41564/91399_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/19035/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19035/49514_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31980/69758_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4860/14118_B_8_6_rna_selected_60x60.jpg) | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/48483/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48483/135650_B_7_4_rna_selected_60x60.jpg) | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | ![](/images/2476/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2476/8403_A_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/38015/1291_B5_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38015/84094_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24291/53337_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37111/72071_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33630/80314_A_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/2310/if_selected_60x60.jpg) | ![](/images/32706/ihc_cell_selected_60x60.jpg) | ![](/images/32706/128664_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | ![](/images/5605/15397_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5606/18338_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/1583/5182_B_7_5_rna_selected_60x60.jpg) | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | ![](/images/16118/36232_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/10207/if_selected_60x60.jpg) | ![](/images/10207/ihc_cell_selected_60x60.jpg) | ![](/images/35116/84725_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39154/83027_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/18673/if_selected_60x60.jpg) | ![](/images/18673/ihc_cell_selected_60x60.jpg) | ![](/images/18673/44187_B_9_1_rna_selected_60x60.jpg) | Mixed |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/64258/1331_H7_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39796/84042_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/56815/ihc_cell_selected_60x60.jpg) | ![](/images/48892/130229_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
CLCN2 | Chloride channel, voltage-sensitive 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/24108/ihc_cell_selected_60x60.jpg) | ![](/images/9397/26823_B_8_4_rna_selected_60x60.jpg) | Mixed |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/43019/102123_B_5_8_rna_selected_60x60.jpg) | Expressed in all |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18174/41703_B_8_1_rna_selected_60x60.jpg) | Group enriched |
MFSD2B | Major facilitator superfamily domain containing 2B | Predicted membrane proteins
| | ![](/images/44145/1364_H5_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44145/99065_B_1_8_rna_selected_60x60.jpg) | Tissue enriched |
MT-CO1 | Mitochondrially encoded cytochrome c oxidase I | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/69328/156309_B_8_8_rna_selected_60x60.jpg) | Expressed in all |
NNT | Nicotinamide nucleotide transhydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/4975/19345_B_8_8_rna_selected_60x60.jpg) | Expressed in all |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70127/151478_B_8_6_rna_selected_60x60.jpg) | Group enriched |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40374/88226_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PKDREJ | Polycystin (PKD) family receptor for egg jelly | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/34587/154174_A_1_8_selected_60x60.jpg) | ![](/images/34587/143598_A_1_4_rna_selected_60x60.jpg) | Tissue enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/41874/144649_A_3_5_selected_60x60.jpg) | ![](/images/41874/86782_B_4_2_rna_selected_60x60.jpg) | Tissue enriched |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22567/52670_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SERINC5 | Serine incorporator 5 | Predicted membrane proteins
| | ![](/images/37899/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37898/78454_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/18107/if_selected_60x60.jpg) | ![](/images/14967/ihc_cell_selected_60x60.jpg) | ![](/images/14967/33483_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28748/141823_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/72058/159045_A_2_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14963/141351_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14736/33478_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37130/72627_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50458/122997_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/9172/ihc_cell_selected_60x60.jpg) | ![](/images/2574/6344_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/37467/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2573/6339_B_2_7_rna_selected_60x60.jpg) | Tissue enriched |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41505/91980_B_8_1_rna_selected_60x60.jpg) | Group enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/24575/ihc_cell_selected_60x60.jpg) | ![](/images/24575/56695_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/35603/146816_A_3_8_selected_60x60.jpg) | ![](/images/35603/72936_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A15 | Solute carrier family 22, member 15 | Predicted membrane proteins Transporters
| | ![](/images/19785/185_E9_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19785/45589_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68236/152461_A_7_8_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/44174/ihc_cell_selected_60x60.jpg) | ![](/images/44174/147449_A_7_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47612/111052_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |